Congrats to Prof @FreyaFowkes on being awarded $2.9 million through the 2026 @nhmrc Investigator Grants scheme for her project, "Novel surveillance strategies to achieve the last mile of malaria elimination in the Asia Pacific."🎉 Read more: acreme.edu.au/congratulati...

👏The study benchmarks Oxford Nanopore MinION technology for real-time, field-deployable whole-genome sequencing of P. falciparum, demonstrating its potential to generate high-quality genomic data for malaria research and public health surveillance 😲 www.microbiologyresearch.org/content/jour...

Dr Shazia Ruybal-Pesántez, PhD tomorrow, Thursday 23 July 2.00pm-3.00pm AEST for our webinar series. 'Understanding Plasmodium vivax resurgence dynamics by integrating genetics and transmission modelling' 🔗https://events.humanitix.com/acreme-webinar-series-2026/tickets

@acreme.bsky.social Call for Applications: MASTER-MAP Travel and Training Awards 🌟 ➡️ To support affiliated PhD students and postdoc researchers in workshops, laboratory exchanges, and field-based training ⏳ Application deadline: 24 July, 5:00 PM AEST 🔗

ACREME Call for Application: MASTER-MAP Travel and Training Awards - MESA

The Australian Centre of Research Excellence in Malaria Elimination Modern Acceleration Strategies for Eradication of Malaria in the Asia-Pacific (ACREME MASTER-MAP) calls for applications for its Travel and Training Awards to support ACREME MASTER-MAP affiliated PhD students and Postdoctoral Researchers to participate in activities such as training workshops, laboratory exchanges, and field-based training. Application deadline, 24 July 2026 5.00pm AEST

mesamalaria.org

The 2026 ACREME Seed Grants are now accepting applications, supporting pilot projects that align with our research themes (Track, Prevent, Treat). Successful projects can receive between AUD $15K–$25K 🔗 acreme.edu.au/grants/seed-... #Malaria #Funding #GlobalHealth #Research

Malaria Modellers Conference Australia (MMCA) is now calling for abstract submissions 🔗 www.mmca2026.org Submissions close at 5:00PM AWST, Friday 31 July 2026 📅14-15 September 2026 🕑10am-5pm AWST 📍Old Perth Technical College, Georges Terrace, Perth WA

The NATNAT project is assessing the feasibility and acceptability of complementary vector control approaches in PNG communities and the health system. These tools include residual spraying, spatial emanators, and larval source management.🔗 link.springer.com/article/10.1...

The 2026 Annual Meeting will bring together researchers for two days of knowledge sharing, collaboration, and capacity building, and will be delivered in conjunction with the Malaria Synergy Program (MSP). Secure your spot now🔗 events.humanitix.com/acreme-and-m...

Volatile pyrethroid spatial emanators (SEs) release active ingredients that deter or kill mosquitoes, and 2 SE products have recently been World Health Organization pre-qualified for malaria vector control. academic.oup.com/jid/advance-...

Stakeholder perceptions of these risks may significantly influence the acceptability and uptake of these regimens. Understanding these perceptions is essential for #policymakers to design effective communication and implementation strategies of novel radical cure strategies. 🔗 lnkd.in/evddyiha

The PAVE SCOPE research was a collaborative program of implementation research across Indonesia/PNG. The evidence has directly informed a change in the treatment guidelines in both countries and MOH are now moving ahead - Professor Leanne Robinson lnkd.in/gTMeCmhR

Antimalarial resistance is one of the greatest threats to malaria elimination🦟 This study reveals a potential previously unconsidered antimalarial resistance mechanism for P. falciparum and provides an assay for surveillance in other populations. 🔗 www.biorxiv.org/content/10.6...

Join us for the next webinar featuring Dr Shazia Ruybal-Pesántez, hosted by Prof Sarah Auburn on Thurs 23 July 2pm-3pm AEDT. Understanding Plasmodium vivax resurgence dynamics by integrating genetics and transmission modelling 🔗Register now: lnkd.in/gnWrnkXy

Our PDS is designed to support researchers and build capacity across the Asia-Pacific region. 🔹 Grant Application Support 🔹 Shadowing Opportunities 🔹 Pitch Presentation Coaching 🔹 Peer Learning and Student Supervision 🔹 Regional Hub Training 📩 acreme.edu.au/what-we-do/o...

The emergence of artemisinin-resistant P.falciparum threatens the utility of the current first-line ACTs. Alternatives to artemisinins are urgently required to progress efforts toward reducing malaria morbidity and mortality. Read the latest findings on MMV367 👉 www.science.org/doi/10.1126/...

To understand the risks and benefits of different primaquine dosing regimens for P. vivax malaria in Ethiopia, researchers undertook a systematic review and individual patient data meta-analysis. Read the latest findings: link.springer.com/article/10.1...

The ACREME Regional Hub Travel and Training Grant is now available, providing up to $7,500AUD to support malaria researchers across the Asia-Pacific region ✈️ 📅 Applications close on 24 July 2026. 👉 Learn more: acreme.edu.au/grants/trave...

Congrats to Prof Jennifer Flegg on being elected as a Fellow of The Australian Academy of Science👏🥂She joins 28 outstanding scientists recognised this year for their exceptional contributions to fundamental discovery, translational research, and the commercial application of science @science.org.au

Applications for ACREME’s 2026 Training and Travel Grants are still open. Applications are welcome for anticipated travel and training activities taking place throughout the 2026 calendar year. 🔗https://acreme.edu.au/grants/travel-and-training-grants/

The EFFORT clinical trial was conducted in four countries to evaluate the safety and effectiveness of high-dose primaquine and single-dose tafenoquine compared with the standard 14-day low-dose primaquine regimen for the radical cure of patients with P.vivax malaria lnkd.in/gM5p5d26

The 2026 ACREME Seed Grants are now accepting applications, supporting pilot projects that align with the ACREME MASTER-MAP research themes acreme.edu.au/grants/seed-...

New findings reveal promising correlates of protection for the RTS,S malaria vaccine and new insights to inform the development of next-generation malaria vaccines. #malaria #vaccines @burnetinstitute.bsky.social @acreme.bsky.social doi.org/10.1371/jour...

New findings reveal promising correlates of protection for the RTS,S #malaria #vaccine and new insights to inform the development of next-generation malaria vaccines. @burnetinstitute.bsky.social @acreme.bsky.social journals.plos.org/plosmedicine...

This publication highlights the use of regional high-resolution genetic data to enhance monitoring of transmission intensity and cross-border importations. academic.oup.com/jid/advance-...

In this study, researchers aimed to examine how genetic variation in P vivax affects the utility of these markers and whether redesigned antigens could improve performance. 🔗 : www.sciencedirect.com/science/arti...

These findings reveal promising new correlates of protection for RTS,S and new insights to inform the development of next-generation malaria vaccines. 🔗 journals.plos.org/plosmedicine...

The ACREME team took some well-earned time out in Bangkok to enjoy a relaxed dinner during the APMEN Joint Working Group Meeting. Sometimes the best collaboration happens over good food and even better company 🤝🌏 #Collaboration #GlobalHealth #Bangkok #Malaria #Network #GlobalCollaboration

Photos from the APMEN Joint Working Group meeting in Bangkok 🦟Great to see @kthriemer.bsky.social & Stephan Karl sharing their insights and contributing to important discussions on malaria elimination across the region. 📷 : Win Han Oo #MalariaElimination #GlobalHealth #EndMalaria

Professor Leanne Robinson of @burnetinstitute.bsky.social recently spoke with Madlen Luckner (Nature Communications), reflecting on her work toward malaria elimination and the evolving challenges and opportunities in the field. Read the full interview: www.nature.com/articles/s41...

This study aimed to evaluate the 7-day low-dose primaquine regimen in G6PD-normal patients with uncomplicated P. vivax and/or P. falciparum malaria in the pre-elimination context of Nepal. 🔗 onlinelibrary.wiley.com/doi/10.1111/...